Molecular marker expression in oral and oropharyngeal squamous cell carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 127, Issue 7, 2001, Pages 780-785

  Smith, Benjamin D ^a   Smith, Grace L ^a   Carter, Darryl ^a   DiGiovanna, Michael P ^a   Kasowitz, Katherine M ^a   Sasaki, Clarence T ^a   Haffty, Bruce G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYCLIN D1; EPIDERMAL GROWTH FACTOR; PROTEIN P53; VASCULOTROPIN;

APOPTOSIS; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONFERENCE PAPER; DNA DAMAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; OROPHARYNX CANCER; PROGNOSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLIN D1; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034941853     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. Smith BD, Haffty BG, Sasaki CT. Molecular markers in head and neck squamous cell carcinoma: their biologic function and prognostic significance. Ann Otol Rhinol Laryngol. 2001;110:221-228.
2. Lane DP. p53, guardian of the genome. Nature. 1992:358:15-16.
3. Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995:20:187-190.
4. Rubin Grandis J, Chakraborty A, Melhem MF, et al. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene. 1997:15:409-416.
5. Calzolari A, Chiarelli I, Blanchi S, et al. Immunohistochemical vs molecular biology methods: complementary techniques for effective screening of p53 alterations in head and neck cancer. Am J Clin Pathol. 1997;107:7-11.
6. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992:359:843-845.
7. Smith BD, Smith GL, Carter D, et al. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal sqaumous cell carcinoma. J Clin Oncol. 2000:18:2046-2052.
8. Beitler JJ, Smith RV, Silver CE, et al. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys. 1998:40:313-317.
9. Haffty B, Son YH, Papac R, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale mitomycin randomized trials. J Clin Oncol. 1997:15:268-276.
10. Haffty BG, Son YH, Wilson LD, et al. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. Radiat Oncol Investig. 1997;5:235-245.
11. American Joint Committee on Cancer. Manual for Staging Cancer. 4th ed. Philadelphia, Pa: JB Lippincott; 1992.
12. Pignataro L, Pruneri G, Carboni N, et al. Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma. J Clin Oncol. 1998;16: 3069-3077.